Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11C A Pawlik, R V Iyengar, E J Krull, et al.
Cancer Chemotherapy and Pharmacology|April 26, 2001
Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID miceJ Thompson, S M Guichard, P J Cheshire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
The Pharmacokinetic-Pharmacodynamic (PKPD) Relationships of AZD3229, a Novel and Selective Inhibitor of KIT, in a Range of Mouse Xenograft Models of GISTVenkatesh Pilla Reddy, Rana Anjum, Michael Grondine, et al.
Cancer Research|September 5, 2002
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patientsLars M Wagner, Sylvie M Guichard, Rebecca A Burger, et al.
Cancer Research|January 25, 2012
Enhanced apoptosis and tumor growth suppression elicited by combination of MEK (selumetinib) and mTOR kinase inhibitors (AZD8055)Sarah V Holt, Armelle Logie, Barry R Davies, et al.
Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.
Journal of Food Protection|May 14, 2009
Public health response to puffer fish (Tetrodotoxin) poisoning from mislabeled productNicole J Cohen, Jonathan R Deeds, Eugene S Wong, et al.
Experimental Hematology|November 16, 2024
FT-4202, a selective pyruvate kinase R activator for sickle cell diseaseAnna Ericsson, David J Richard, Erik Wilker, et al.
Targeted Oncology|February 24, 2023
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast CancerMaureen Caligiuri, Grace L Williams, Jennifer Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated SurvivalEmilio Cosimo, Anuradha Tarafdar, Michael W Moles, et al.
Pageof 11